老百姓(603883.SH)擬6.8億元收購人川大藥房100%股權
格隆匯 12 月 20日丨老百姓(603883.SH)公佈,公司與交易方上海騁臻企業管理合夥企業(有限合夥)、上海鉑熠企業管理諮詢服務中心(有限合夥)、上海歆臻營銷策劃服務中心(有限合夥)、濟南歆騁企業管理有限公司簽訂《股權收購協議》,擬以自有資金收購其持有赤峯人川大藥房連鎖有限公司(以下簡稱"人川大藥房"或"目標公司")100%的股權,收購金額為人民幣6.8億元。
公告稱,人川大藥房位於內蒙古人口最多的城市赤峯市,是赤峯市最大的藥品零售連鎖企業,有着良好的市場聲譽和口碑,門店經營質量優良,未來仍可通過中小型併購和新開門店模式繼續擴大市場佈局密度,發展空間較大。
此次收購符合公司發展戰略,目標公司所在的內蒙古市場是公司重點發展省份。公司已有控股子公司內蒙古通遼澤強,已經在內蒙古當地組建了豐富經驗的醫藥零售經營團隊,同時形成了良好的市場口碑。通過此次收購,目標公司將與通遼澤強大藥房強勢合力,進一步擴展內蒙古市場,加強公司對上游供應商的議價能力,降低產品的採購成本,整合內蒙地區地採資源。同時公司通過委派管理層,全面整合目標公司業務,實現快速發展。
此外,次收購完成後,將有助於提高公司的行業競爭力和品牌影響力,對公司的長遠發展具有重要意義,此次收購不存在損害公司及股東利益的情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.